It was reported that the right ventricular (rv) threshold had been rising since implant of the implantable cardioverter defibrillator system.In (b)(6) 2023 threshold was 1.7 v and in (b)(6) 2024, at the time the patient underwent valve surgery, it was 2.7 v.The patient attended a follow-up appointment in (b)(6) 2024 at which time it was noted that a presenting electrogram demonstrated rv loss of capture and that the patient had been in atrial fibrillation since the valve surgery.The rv output was increased.An upcoming cardioversion was planned, and the patient was to discuss the possibility of rv lead replacement at a subsequent follow-up.The rv lead remains in service.
|
It was reported that the right ventricular (rv) threshold had been rising since implant of the implantable cardioverter defibrillator system.In (b)(6) 2023 threshold was 1.7 v and in (b)(6) 2024, at the time the patient underwent valve surgery, it was 2.7 v.The patient attended a follow-up appointment in (b)(6) 2024 at which time it was noted that a presenting electrogram demonstrated rv loss of capture and that the patient had been in atrial fibrillation since the valve surgery.The rv output was increased.An upcoming cardioversion was planned, and the patient was to discuss the possibility of rv lead replacement at a subsequent follow-up.The rv lead remains in service.Additional information received indicated that the rv lead was explanted and replaced.No additional adverse patient effects were reported.The lead was received for analysis.
|